Table 1.
Reported cases of mixed corticomedullary tumours
Reference | Age/gender | Clinical presentation | Hormones secreted | Tumour size (cm) |
---|---|---|---|---|
Mathison and Waterhouse,2 1969 | 39 F | Cushing syndrome, intraoperative HTN | Cortisol, ACTH*, catecholamines | 4 |
Akai et al,3 1993 | 61 F | HTN, hyperglycaemia | Cortisol, ACTH*, catecholamines | 3.5 |
Ohta et al,4 1995 | 32 M | Cushing syndrome, intraoperative HTN | Cortisol, ACTH* | 4.5 |
Michal and Havlicek5 1996 | 56 F | Cushing syndrome, HTN | Cortisol, aldosterone, catecholamines | 8 |
32 F | Cushing syndrome, HTN | Cortisol, aldosterone, catecholamines | 9 | |
Wieneke et al,1 2001 | 34 F | HTN, hair loss, amenorrhoea | Cortisol | 4.5 |
52F | Flank pain | None | 2.5 | |
Chu et al,6 2003 | 55 F | Mild Cushing syndrome | Cortisol, ACTH* | 2.5 |
Ma et al,7 2007 | 41 F | Cushing syndrome, intraoperative HTN | Cortisol, ACTH* | 4 |
Lee et al,8 2008 | 25 F | Cushing syndrome, gestational diabetes, HTN | Cortisol, catecholamines | 3.2 |
Kimura et al,9 2009 | 54 F | HTN, diabetes | Cortisol, catecholamines | 4.9 |
Alexandraki et al,10 2009 | 66 F | Subclinical Cushing syndrome | Cortisol, ACTH* | 4.2 |
Singh et al,11 2010 | 48 F | Abdominal distention, pedal oedema | Catecholamines | 8 |
Lau et al,12 2011 | 64 F | HTN | Catecholamines | 3.6 |
Donatini et al,13 2013 | 53 M | Right flank pain | Catecholamines | 5.5 |
Turk et al,14 2012† | 78 F | Hypertensive urgency | Catecholamines | 10 |
Michalopoulos et al,15 2013† | 63 M | Right upper quadrant palpable mass | Cortisol, ACTH* | 8 |
Total number of cases: 17 | Median age 53.5 years (range 25–78) Females 82% (14/17) Males 18% (3/17) |
Cushing syndrome 47% (8/17) Intraop HTN 18% (3/17) HTN 47% (8/17) |
Cortisol 71% (12/17) Aldosterone 12% (2/17) Catecholamines 59% (10/17) ACTH* 88% (7/8) |
Median size 4.5 cm (range: 2.5–10) |
*ACTH was detectable (non-suppressed) in the setting of hypercortisolaemia.
†Mixed corticomedullary carcinoma (MCMC).
HTN, hypertension; Intraop, intraoperative.